Improving quality of life in patients with end-stage age-related macular degeneration: Focus on miniature ocular implants

Clinical Ophthalmology

Volumn 6, Issue 1, 2011, Pages 33-39

  Singer, Michael A ^a   Amir, Nancy ^b   Herro, Angela ^c   Porbandarwalla, Salman S ^c   Pollard, Joseph ^a  

^a Medical Center Ophthalmology Associates   (United States)

^b Santa Rosa Low Vision Clinic   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Argus II; IMT; IOL VIP; LMI

Indexed keywords

ANTERIOR EYE SEGMENT; CORNEAL ENDOTHELIAL CELL LOSS; DEPTH PERCEPTION; EQUIPMENT DESIGN; EYE MOVEMENT; HAND MOVEMENT; HEAD MOVEMENT; HUMAN; IMAGE PROCESSING; IMPLANT; IMPLANTABLE MINIATURE TELESCOPE; IMPLANTATION; INSTRUMENT; INTRAOCULAR IMPLANT; INTRAOCULAR MIRROR TELESCOPIC INTRAOCULAR LENS; LENS IMPLANT; MAGNIFIER; POSTERIOR EYE SEGMENT; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; QUESTIONNAIRE; REHABILITATION CARE; RETINA MACULA AGE RELATED DEGENERATION; RETINAL IMPLANT; RETINAL PROSTHESIS; REVIEW; SAFETY; SPECTACLES; TELESCOPE; VESTIBULOOCULAR REFLEX; VISION; VISUAL ACUITY; VISUAL AID; VISUAL FUNCTIONING QUESTIONNAIRE; VISUAL REHABILITATION;

EID: 84856191188     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S15028     Document Type: Review

References (29)

1. Friedman DS, O'Colmain BJ, Munoz B, et al; for the Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4): 564-572.
2. Gohdes DM, Balamurugan A, Larsen BA, Maylahn C. Age related eye diseases: an emerging challenge for public health professionals. Prev Chronic Dis. 2005;2(3):A17. Available from: http://www.cdc.gov/pcd/issues/2005/jul/04_0121.htm. Accessed August 1, 2011.
3. AREDS Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, β-carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119(10):1439-1452.
4. Chun DW, Heier JS, Raizman MB. Visual Prosthetic Device for bilateral end-stage macular degeneration. Expert Rev Med Devices. 2005;2(6):657-665.
5. Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR. T{stroke}ransdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1996;37(5):855-868.
6. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419-1431.
7. Brown DM, Kaiser PK, Michels M, etal. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432-1444.
8. Martin DF, Maguire MG, Ying GS, et al; CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364(20): 1897-1908.
9. Sunness JS. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis. 1999;5:25.
10. Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998; 116(4):514-520.
11. Casten RJ, Rovner BW, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol. 2004;15(3):181-183.
12. Brown MM, Brown GC, Sharma S, Kistler J, Brown H. Utility values associated with blindness in an adult population. Br J Ophthalmol. 2001;85(3):327-331.
13. Peli E. The optical functional advantages of an intraocular low-vision telescope. Optom Vis Sci. 2002;79(4):225-233.
14. Nguyen A, Nguyen A-T, Hemenger RP, Williams DR. Resolution, field of view, and retinal illuminance of miniaturized bioptic telescopes and their clinical significance. J Vis Rehab. 1993;7:5-9.
15. Bailey IL. Critical view of an ocular telephoto system. CLAO J. 1987; 13(4):217-221.
16. Orzalesi N, Pierrottet CO, Zenoni S, Savaresi C. The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease. Ophthalmology. 2007;114(5):860-865.
17. Hudson HL, Lane SS, Heier JS, et al; IMT-002 Study Group. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology. 2006;113(11):1987-2001.
18. Colby KA, Chang DF, Stulting RD, Lane SS. Surgical placement of an optical prosthetic device for end-stage macular degeneration: the implantable miniature telescope. Arch Ophthalmol. 2007;125(8): 1118-1121.
19. Hudson HL, Stulting RD, Heier JS, et al. IMT002 Study Group. Implantable telescope for end-stage age-related macular degeneration: long-term visual acuity and safety outcomes. Am J Ophthalmol. 2008. 146(5):664-673.
20. Primo SA. Implantable miniature telescope: lessons learned. Optometry. 2010.81(2):86-93.
21. Bansal AS, Baker P, Haller JA. An implantable visual prosthetic for end-stage macular degeneration. Expert Rev Ophthalmol. 2011.6(2): 141-145.
22. Agarwal A, Lipshitz I, Jacob S, et al. Mirror telescopic intraocular lens for age-related macular degeneration: design and preliminary clinical results of the Lipshitz macular implant. J Cataract Refract Surg. 2008. 34(1):87-94.
23. Ahuja AK, Dorn JD, Caspi A, et al. Argus II Study Group. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br J Ophthalmol. 2011.95(4): 539-543.
24. Alio JL, Mulet EM, Jose M, Ruiz-Moreno, Sanchez MJ, Galal A.; Intraocular telescopic lens evaluation in patients with age-related macular degeneration. J Cataract Refract Surg. 2004.30(6):1177-1189.
25. Implantable Miniature Telescope Professional Use Information, FDA-approved product labeling. Retrieved September 29, 2011. Available from: http://www.centrasight.com/pdf/ProfessionalUse2010.pdf. Accessed October 27, 2011.
26. Second Sight to Double Patient Enrollment for Argus II Retinal Implant US. Clinical Trial. Second Sight Medical Products, Inc. May 4, 2009. Web. August 1, 2011. Available from: http://www.2-sight.com/SSMP_ARVO_2009.pdf. Accessed October 27, 2011.
27. "System Overview." Retrieved August 30, 2011. Available from: http://www.2-sight.eu/ee/system-overview. Accessed October 27, 2011.
28. Graf HG, Harendt C, Engelhardt T, et al. High dynamic range CMOS imager technologies for biomedical applications. IEEE Journal of Solid-State Circuits. 2009.44(1):281-289.
29. Brown GC, Brown MM, Lieske HB, Lieske PA, Brown KS, Lane SS. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope. Ophthalmology. 2011.118(9):1834-1843.